(Q74607911)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10078606%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

title

Phase I safety and antigenicity of TA-GW: a recombinant HPV6 L2E7 vaccine for the treatment of genital warts (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10078606%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

author name string

H S Thompson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10078606%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

M L Davies

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10078606%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

F P Holding

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10078606%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

R E Fallon

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10078606%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

A E Mann

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10078606%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

T O'Neill

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10078606%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

J S Roberts

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10078606%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

language of work or name

English

0 references

publication date

1 January 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10078606%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10078606%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10078606%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10078606%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

page(s)

40-49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10078606%20AND%20SRC:MED&resulttype=core&format=json

Human papillomavirus infection and genital warts: update on epidemiology and treatment

12 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900146-7

7 January 2021

Epidemiology of Genital Human Papillomavirus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900146-7

7 January 2021

Therapeutic approaches to genital warts

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900146-7

7 January 2021

Treatment of Condyloma Acuminata by Autogenous Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900146-7

7 January 2021

Long-term effectiveness of the immunotherapy of anal condyloma acuminatum

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900146-7

7 January 2021

Autogenous vaccine: the best therapy for perianal condyloma acuminata?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900146-7

7 January 2021

Immunological events in regressing genital warts

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900146-7

7 January 2021

Epidermotropism of T cells correlates with intercellular adhesion molecule (ICAM1) expression in human papillomavirus (HPV)-induced lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900146-7

7 January 2021

Analysis of HLA-DR expression on keratinocytes in cervical neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900146-7

7 January 2021

Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900146-7

7 January 2021

Incidence of venereal warts in human immunodeficiency virus-infected and uninfected women

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900146-7

7 January 2021

Studies on vaccination against papillomaviruses: Prophylactic and therapeutic vaccination with recombinant structural proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900146-7

7 January 2021

Prophylactic and therapeutic vaccination against a mucosal papillomavirus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900146-7

7 January 2021

Immunization with nonstructural proteins E1 and E2 of cottontail rabbit papillomavirus stimulates regression of virus-induced papillomas

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900146-7

7 January 2021

Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900146-7

7 January 2021

The nucleotide sequence and genome organization of human papilloma virus type 11.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900146-7

7 January 2021

Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900146-7

7 January 2021

Establishment of stable, cell-mediated immunity that makes "susceptible" mice resistant to Leishmania major.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900146-7

7 January 2021

Vaccine strategies: selective elicitation of cellular or humoral immunity?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900146-7

7 January 2021

Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900146-7

7 January 2021

Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900146-7

7 January 2021

Antigen presentation by keratinocytes induces tolerance in human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2898%2900146-7

7 January 2021

10.1016/S0264-410X(98)00146-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10078606%20AND%20SRC:MED&resulttype=core&format=json

12 November 2019

1 reference